Symptomatic treatment of proteinuria
D.Jong, P.E.
Pediatric Nephrology 8(5): C30
1994
ISSN/ISBN: 0931-041X Accession: 033611817
Full Text Article emailed within 1 workday: $29.90
Related References
Bourgoin, P.; Masseyeff, R. 1962: Immunoelectrophoretic analysis of symptomatic proteinuria symptomatic of late pathological pregnancy Gynecologie et Obstetrique 61: 378-384Gansevoort, Ron T.; Heeg, Jan E.; Dikkeschei, Bert D.; De Zeeuw, Dick; De Jong, Paul E.; Dullaart, Robin P.F. 1993: Symptomatic antiproteinuric treatment decreases serum Lp concentration in patients with glomerular proteinuria Journal of the American Society of Nephrology 4(3): 275
Gansevoort, R.T.; Heeg, J.E.; Dikkeschei, F.D.; de Zeeuw, D.; de Jong, P.E.; Dullaart, R.P. 1994: Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 9(3): 244-250
Sakai, T.; Iidaka, K. 1988: Non-symptomatic proteinuria and hematuria Nihon Rinsho. Japanese Journal of Clinical Medicine 46(6): 1428-1433
Odabas, A.R.; Cetinkaya, R.; Selcuk, Y.; Bilen, H. 2001: Effect of losartan treatment on the proteinuria in normotensive patients having proteinuria due to secondary amyloidosis Upsala Journal of Medical Sciences 106(3): 183-188
Suzuki, T.; Yamamoto, T.; Ohura, M.; Fujigaki, Y.; Yonemura, K.; Kimura, M.; Hishida, A. 2004: Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0 g/day Clinical and Experimental Nephrology 8(3): 243-249
Tapia, E.; Sánchez-González, D.J.; Medina-Campos, O.N.; Soto, V.; Avila-Casado, C.; Martínez-Martínez, C.M.; Johnson, R.J.; Rodríguez-Iturbe, B.; Pedraza-Chaverrí, J.é; Franco, M.; Sánchez-Lozada, L.G. 2008: Treatment with pyrrolidine dithiocarbamate improves proteinuria, oxidative stress, and glomerular hypertension in overload proteinuria American Journal of Physiology. Renal Physiology 295(5): F1431-F1439
Atkins, R.C.; Briganti, E.M.; Wiegmann, T.B. 2002: Effect of baseline proteinuria and change in proteinuria with treatment on the risk of renal endpoints in the irbesartan diabetic nephropathy trial Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 7A
Shimizu, F. 2004: Responsible genes for proteinuria and concept of the treatment for proteinuria Nihon Rinsho. Japanese Journal of Clinical Medicine 62(10): 1800-1804
Kunin, C.M. 1968: Emergence of bacteriuria, proteinuria, and symptomatic urinary tract infections among a population of school girls followed for 7 years Pediatrics 41(5): 968-976
King, S.E. 1959: Albuminuria (proteinuria) in renal diseases. I. the significance of persisting albuminuria (proteinuria): proteinuria patterns and their clinical application New York State Journal of Medicine 59(5): 818-824
Vincent, D.; Magron, J. 1978: Cholin esterase aryl esterase and proteinuria a clinical trial in glomerular proteinuria and tubular proteinuria Clinica Chimica Acta 90(1): 1-6
Schaefer, W.; Langen, P.H.; Jakse, G.; Offermann, R.; Lymberopoulos, S.; Ruebben, H. 1991: Urodynamics and symptomatic changes after surgical treatment of symptomatic benign prostatic hyperplasia Journal of Urology 145(4 Suppl): 390A
González-Calle, V.; Dávila, J.; Escalante, F.; de Coca, A.G.; Aguilera, C.; López, R.; Bárez, A.; Alonso, J.M.; Hernández, R.; Hernández, J.M.; de la Fuente, P.; Puig, N.; Ocio, E.M.; Gutiérrez, N.C.; García-Sanz, R.; Mateos, M.V. 2016: Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma Leukemia 30(10): 2026-2031
Tekle, W.G.; Chaudry, S.A.; Hassan, A.E.; Qaiser, H.; Grigoryan, M.; Rodriguez, G.J.; Qureshi, A.I. 2014: High risk of new episode of symptomatic vasospasm in unaffected arteries in subarachnoid hemorrhage patients receiving targeted endovascular treatment for symptomatic focal vasospasm Neurocritical Care 20(3): 399-405